In the past, all practices that offered Carefree Credit to clients had to complete the FCA authorisation process, something which involved completing a 48 page online application and a wait of 12 weeks for approval. Although Carefree Credit provides guidance with the process and around 700 practices have enrolled successfully, it was not the ideal solution for practices who wanted a quick solution.
From now on, those practices that are happy to offer interest-free credit for a maximum period of 12 months can do so without going through the FCA process.
Stewart Halperin MRCVS, the founder of Carefree Credit, said: "For those of you who have looked at a client finance option for your practice but have been put off by the thought of going through the FCA authorisation process, this will make things much easier."
For more information, visit www.carefreecredit.co.uk/
The London Vet Show will next take place on 11th and 12th November 2021 at the ExCeL Center, London.
CloserStill says the decision to cancel was made following several discussions with industry stakeholders, including partners, and considering the significant impact of both international and domestic travel.
Rob Chapman, MD of CloserStill’s veterinary portfolio, said: "COVID-19 has brought enormous pressures and uncertainty to the veterinary sector - both personally and professionally.
"Although the UK Government gave the green light for exhibitions and meetings to start again in October, after examining at the overall market and consultation with our partners, we feel the decision to postpone is in the best interest of the veterinary community.
"Although this news may be disappointing to those looking forward to the London Vet Show, unfortunately the coronavirus situation is continually developing. We want to be as clear and upfront as possible with our community and customers, and after careful consideration, our decision to reschedule was out of caution. As event organisers, the health and safety of our exhibitors, delegates, speakers, staff and supporters, is our number one priority."
"Obviously the postponement decision hasn’t been easy but we firmly believe it’s the right thing to do. We are so fortunate to have support of great partners like the Royal Veterinary College and the British Veterinary Association, along with the exhibitors, speakers and delegates we’ve spoken to so far; everyone has been really understanding. We can’t wait to see you all again virtually soon, and in person in 2021."
"The team and I are eager to continue to provide world-class education to veterinary professionals, to connect and encourage networking to foster the advancement of the veterinary sector. We are developing some great opportunities for the veterinary community come November. We will be announcing more details on this very soon."
The company says that practices transferring to its pet health plan portal will be able to take greater control of their pet health plans and benefit from a range of innovative services for the same cost. They include the VMD-approved Post2Pet home delivery service, a messaging system to advise clients on applying products, attending appointments or renewing prescriptions, reporting to give practice leaders the insights they need to drive plan performance, the ability for pet owners to sign up online rather than visit the practice, and 24/7 access to a marketing hub and the Premier Vet Alliance Learning Academy.
Premier Vet Alliance’s Business Development Director Andy Taylor said: "We are excited to be offering our high performing Premier Pet Care Plan to the many new practices joining us following our acquisition of Simplyhealth’s animal health business.
"We are working to make the transition seamless and believe that our new customers will be delighted at the expanded range of functionality our portal offers them, together with the reduced administrative burden. We will continue to invest in its development to ensure that all of our customers can be sure that their pet health plan offers the most powerful set of tools and services available to help them drive up the profitability of their practice, while offering gold standard care to their patients and peace of mind to their clients."
For more information, visit: https://premiervetalliance.com/uk/
Hertfordshire-based, multi-specialist veterinary referral centre Davies Veterinary Specialists' new pro bono scheme has saved the life of a young German shepherd dog twice in fortnight.
'Apollo' first impaled himself on some broken fence panels whilst playing. A splinter of wood, which was around 5cm long and 1.5cm wide, became lodged between his heart and lungs. However, because he initially had no symptoms and there was no obvious puncture wound, his owner Sam Russell from Leighton Buzzard wasn't aware that anything was wrong. It was a week later when the dog suddenly became very anxious, uncomfortable and was struggling to breathe, that Sam rushed him to her local vet practice, Heath and Reach in Bedfordshire.
Hannah Johnston's initial diagnosis was that the dog had some foreign material lodged internally that was causing an infection. Without an urgent CT scan and surgery his chances of survival were minimal, but his owner was uninsured and had no means of affording the treatment. Hannah had recently read about a pro bono scheme introduced by Davies Veterinary Specialists and believed that Apollo's case fitted the criteria.
She said: "It was heart wrenching to think that a young dog, with such a caring owner, was very likely to lose his life and I was determined to do anything I could to help. I couldn't help shedding a tear when DVS agreed to treat him, as I knew Apollo now had a chance. His owner had recently had an awful spate of bad luck and was so deserving of DVS's help."
Manuel Jiménez Peláez, European Veterinary Specialist in Surgery at DVS, who operated on Apollo, said: "A CT scan showed a large, fluid-filled cavity, a partially collapsed lung and a sharp, thin, elongated structure, lodged between Apollo's lungs and his heart. We drained the cavity and successfully removed the foreign body. We also had to remove most of the irreparably damaged left lung."
Apollo was in hospital for two weeks, five days of which were spent in intensive care in a critical condition. Sam was thrilled when she was eventually able to take him home, but two days later disaster struck again. Apollo was diagnosed with gastric dilation volvulus. He needed surgery within six hours to survive the condition and DVS once again stepped in to operate as an emergency, free of charge.
Apollo has made a full recovery is now back at home with the Russell family. Sam Russell said: "Apollo has always been so determined and full of life. Even when he was dangerously ill and in intensive care he wouldn't give up and tried to rouse himself to come home with me. For Davies Vet Specialists to save my dog once is nothing short of amazing but for them to save him twice makes me speechless with gratitude. To be shown such kindness after a dreadful run of bad luck would leave anyone stuck for words."
All first opinion practices are eligible to apply for the DVS pro bono scheme, which will allow an average of one patient per month to receive free treatment. Requests will be based on advocacy from the clinical head of the referring practice and on genuine need. To find out more visit http://www.vetspecialists.co.uk/ or call Dr Clive Elwood, Managing Director, on 01582 883950.
Sponsored by Boehringer Ingelheim, the Practice Marketing Award is free to enter, and open only to veterinary practices.
Entries need to demonstrate initiative and/or innovation in the marketing of the practice's services and/or products to clients or the general public during 2017. Eligible entries for the award can include: display advertising, direct mail or electronic media, such as email or websites.
VMA Awards Chair Claire Edmunds said: "Practices have often done a much better job of marketing than they think! And even if they don’t win, entering is great experience and the awards event provides an opportunity to network in the profession. As marketing is becoming an ever more important component in practice success, we would like to encourage as many practices as possible to enter the award."
Last year’s winner Vicky Scutt, joint owner and senior vet at Whitstable Bay Veterinary Centre, said: "Winning the Practice Marketing Award is a real highlight of my career so far! Receiving such a prestigious national award for our practice marketing proves the importance of staying true to your beliefs in business. It gave us the confidence to keep to the same message - because it's clearly working!"
The deadline for submissions is of 2nd February 2018, and the awards are presented on 16th March 2018 in the newly refurbished 5-star Royal Lancaster London hotel.
To enter the Practice Marketing Award, visit: https://www.vma.org.uk/vma-award-categories/practice-marketing-award-entry/
To book event tickets, visit: http://www.vma.org.uk/events/vma-annual-advertising-awards/
For any other information, visit: www.vma.org.uk, email: secretary@vma.org.uk or telephone 0330 223 2259.
Dr Kalisz faced a total of nine charges (including 41 sub-charges).
The first was that in July 2020, she failed to carry out a clinical examination of the dog, failed to adequately interpret test results, failed to ask for help interpreting the results, and undertook an emergency Caesarean section without sufficient need to do so.
The other charges related to undertaking a colotomy without sufficient justification and without exercising sufficient clinical judgment throughout the procedure.
For both the Caesarean section and the colotomy, Dr Kalisz faced charges that she failed to obtain informed consent from the owners and failed to inform them that the colotomy had been carried out, or of the potential risks of the procedure, and also failed to provide enough information about aftercare.
It was also alleged that Dr Kalisz had demonstrated continual lapses in professional judgement, including failing to appropriately manage the spaniel’s worsening condition when it was presented to the practice again later, and that the clinical records in relation to the surgery were dishonest and/or misleading.
Dr Kalisz admitted serious professional misconduct, admitting to 29 of the sub-charges, while the remaining 12 sub-charges were denied.
The Committee found 30 of the sub-charges proven, with the remaining 11 not proven.
The Committee the considered aggravating factors, including the fact that Dr Kalisz's conduct led to the spaniel’s death, the colotomy was reckless and Dr Kalisz did not take steps to inform anybody or make a clinical record for the colotomy.
In mitigation, the Committee considered the fact that it was single and isolated incident (albeit one that spanned a number of days), that no other members of the clinical team involved raised concerns during the procedure, and the effect Covid had upon the veterinary profession.
The Committee found that of those charges proven, the ones relating to performing the colotomy, failing to manage the spaniel’s subsequent care and failing to mention the colotomy amounted to serious professional misconduct.
On deciding the sanction, the Committee took into account the mitigation submitted on behalf of Dr Kalisz and the written testimonials produced including the fact that she was young and inexperienced, had admitted her failings at an early stage, had made subsequent efforts to avoid a repetition of such behaviour and that a significant amount of time had passed since the incident.
The Committee also considered that Dr Kalisz had shown an exemplary level of insight, showing remorse for her actions, undertaking substantial continuing professional development, and finding appropriate ongoing professional mentorship.
The Committee was impressed by the character testimonials from veterinary co-workers, both current and at the time of these events, as well as from clients.
It was, the Committee said, apparent from those testimonials that Dr Kalisz had been open and honest with them about the charges and was considered to be an excellent, committed veterinary surgeon.
Paul Morris, chairing the Committee and speaking on its behalf said: “The Committee found that this was a single isolated incident, which involved serious lapses of clinical judgement.
"It was therefore concluded that, despite Dr Kalisz’s actions being reckless, the extensive mitigation and the high level of insight, coupled with steps taken to avoid repetition, meant that there was negligible future risk to animal welfare.
“The Committee did not consider it necessary to issue a warning to Dr Kalisz about her future conduct, on the basis that the Committee has concluded that there is little risk of repetition, so considered that a reprimand would be an appropriate sanction in this case.”
https://www.rcvs.org.uk/concerns/disciplinary-hearings
Vouchers for twelve months' free access to Improve's Online Bitesize CPD series will be offered to veterinary surgeons, nurses and practice managers by their Protexin Territory Manager, based on their use of products in the Protexin range.
Online Bitesize CPD offers veterinary professionals the opportunity to meet their annual CPD requirements in short bursts of learning at a time and place to suit them. Its online modules of 20, 40 and 60 minutes cover a range of clinical topics, including cardiology, ophthalmology, small animal medicine, feline medicine and exotics.
Improve says the modules have been designed to be visually engaging, highly interactive and informative to ensure that the experience is rewarding.
James Kyffin, Veterinary Director at Protexin, said: "We are thrilled to be continuing our relationship with Improve International by offering practices access to its Online Bitesize CPD. We are passionate about education and Bitesize offers a convenient, exciting way for the profession to gain access to high quality CPD."
John Douglass at Improve International added: “We hope that veterinary professionals who have not yet experienced our training will take up the opportunity created by this association with Protexin Veterinary and learn new skills with our Online Bitesize CPD service for twelve months at no cost.
"The interactive modules we have created are led by recognised experts and will help them to refresh their knowledge, learn new skills and achieve their annual CPD points quota online at any time.”
Esteban Gonzalez joins the practice in Southfields, Laindon, from Ars Veterinaria in Barcelona, one of the leading veterinary hospitals in Spain.
Esteban (pictured right with VRCC Clinical Director, Henry L’Eplattenier) graduated at the Autonomous University of Barcelona (UAB) in 2002. After working as a veterinary emergency in Paris for a year, he did an 18-month rotating internship of at the UAB. He then worked for three years in a veterinary hospital as a soft tissue and emergency surgeon.
In January 2009, he began a three-year residency in small animal surgery in Neuilly-sur-Seine, France, under the supervision of Dr Jean-Francois Bardet, one of France’s leading veterinary surgeons.
As part of his training, he made several visits to the US with graduates of American surgery, as well as specialists in oncology, anaesthesia and emergency medicine.
During his residency he published several articles and gave presentations at national and international conferences.
Esteban graduated as a European specialist in surgery and a diplomate of the European College of Veterinary Surgeons (ECVS) in February 2014. He then worked as a specialist surgeon in the UK for two years until last year when he joined Ars Veterinaria.
VRCC says his is the first of a number of planned appointments which will result in two veterinary surgeons appointed to each of the practice’s eight specialities.
The business is also undergoing a rebranding and rebuilding operation that will see the practice renamed as Southfields.
Operations manager Daniel Hogan said: "The recruitment plan will ensure we continue to offer state-of-the-art veterinary medicine across the board — in oncology, soft tissue surgery, orthopaedics, internal medicine, feline medicine, anaesthesia, diagnostic imaging, neurology and cardiology."
Clinical director at VRCC Henry L’Eplattenier said: "Esteban is a hugely experienced and well-respected specialist, who we are delighted has chosen to join the team here.
"Having his kind of expertise adds to our already considerable skill-sets and is part of a major drive to attract some of the best people in the industry to VRCC."
For more information, visit www.vrcc.co.uk.
The Blue Cross is calling for nominations from veterinary practices across the country for its Veterinary Nurse of the Year Award 2010.
The annual award is presented at the British Veterinary Nursing Association (BVNA) Annual Congress in October. It recognises the contribution of veterinary nurses in educating the public about responsible pet ownership and the welfare of pets in the community.
Last year's award was won by Vania Brasseleur for her outstanding contribution to animal welfare, both within her veterinary practice and among the local community in Newport Pagnell, Buckinghamshire
Vania was nominated for the award by student vet nurse and colleague Emily Martin at Astonlee Veterinary Hospital in Newport Pagnell.
Emily said: "Vania is committed to helping student nurses broaden their knowledge and help them on to the path to qualification. Her charity work, serving the public, helping colleagues and of course her nursing abilities are all truly fantastic! I don't think anybody could ask for a better nurse."
Nominations for this year's award can be made by completing the nomination form on The Blue Cross website at: www.bluecross.org.uk/BVNA2010 or by contacting Sally Leathem on 01993 825577. The deadline for nominations is Friday 20 August 2010.
The new line, which is available from veterinary wholesalers, is described as a complete feeding solution with everyday wet and dry food and treats. It is made with a minimum of 95% fresh, organic ingredients from controlled and certified origins, presented in an eco-friendly packaging. This, says Dechra, means it is tasty, nutritious and better for the environment.
The wet diets for cats contains organic chicken or fish whilst the dog food contains organic beef or fish.
The Specific treats are made with more than 80% fresh chicken, beef and pork. Dechra says that in taste tests, nine out of ten cats, and 100% of dogs accepted the treats1.
Dechra highlights that unlike competitor products, which use layers of different plastic in their packaging which cannot be recycled, Specific uses single layers of the same plastic with a gas barrier in between. This makes its dry pet food bags fully recyclable, as well as lighter and stronger than PET/PE laminates of the same thickness2.
Once Specific dry pet food bags have been used and recycled, they can be processed into granules and made into a film which can be used to make new things – including dry pet food bags.
Dechra Brand Manager Claire Morgan said: “The exciting new range of organic food that’s as kind to the environment as it is to pets.
"The Specific organic range provides a new option for owners who are committed to providing their animals with the optimum chance of good health. The tried and trusted Specific brand is already available for vets to stock so this is a useful addition for practices looking to add value to the service they provide to pet owners.
"We have committed to making all of our packaging fully recyclable by 2023, starting with the Specific organic range. As well as providing a more ethical and environmentally sound choice for eco-conscious pet owners, it’s part of Dechra’s ‘Circle of Good’ commitment to reduce our business’ impact on the world.”
For more information visit: www.specific-diets.co.uk.
References
Norbrook Laboratories Ltd has launched a new addition to the Loxicom range: Loxicom 0.5mg/ml Oral Suspension for Cats.
Offering alleviation from inflammation and pain, Loxicom Oral Suspension for Cats is billed by Norbrook as 'the new cost-effective treatment for chronic musculo-skeletal disorders in cats that is bio-equivalent to the pioneer.'
The Loxicom range now offers vet practices a choice between 5mg/ml Solution for Injection for Dogs and Cats, 1.5mg/ml Oral Suspension for Dogs and now 0.5mg/ml Oral Suspension for Cats.
Loxicom Oral Suspension for Cats is available in a clear 15ml bottle allowing veterinary surgeons and their clients to monitor product levels and re-order when necessary. The packaging also includes a graduated syringe in 0.5kg increments (from 0.5-10kg) which plugs securely into the bottle allowing accurate, mess-free administration.
Norbrook's small animal range also includes Carprieve, a range of carprofen tablets and injection and Noroclav, the amoxycillin / clavulanic acid range of tablets and injection.
Norbrook has announced the launch of Marbodex Aural, the most recent addition to its Otitis Management System for dogs.
Norbrook says the ingredients in Marbodex Aural (marbofloxacin, clotrimazole, dexamethasone) are proven to relieve pain and inflammation quickly, deal with key bacterial and fungal infections effectively and thereby improve pet comfort.
The company says the inclusion of marbofloxacin makes Marbodex Aural an ideal first choice for cases of otitis externa that are:
Marbodex Aural also contains clotrimazole, a broad spectrum antifungal effective against otitis caused by Malassezia pachydermatis, and dexamethasone, a fast acting steroid whose absorption is not increased in inflamed ears.
Marbodex Aural is applied once a day and has two soft nozzles to reduce pain on application and prevent cross-contamination during treatment. It can be used for extended treatment periods of seven to fourteen days when treating persistent infections.
Marbodex Aural is available in all veterinary wholesalers now. For more information about Marbodex and to take advantage of the launch offers, contact your Norbrook Territory Manager or call 01536 741147 for more information.
Reference:
The company says the acquisition is a natural fit for its behavioural range and will bolster its Adaptil portfolio with a wider variety of anxiety solutions for dogs.
Abbie King, senior behaviour product manager at Ceva Animal Health, said: “We have always been fans of the ThunderShirt range and we are therefore delighted with the acquisition, which will further strengthen our extensive portfolio of behavioural products that work in synergy with one another to provide pet owners with comprehensive anxiety solutions.”
For more information, visit: www.thundershirt.com
The RCVS announced in a tweet yesterday afternoon that it will be retaining postnominals on the Register.
#RCVScouncil agrees to retain postnominals on Register. Proposals to improve clarity to come back to future meeting. — RCVS (@RCVS_UK) June 5, 2014
#RCVScouncil agrees to retain postnominals on Register. Proposals to improve clarity to come back to future meeting.
VetSurgeon understands that the proposals to improve clarity may yet involve some rationalisation of the postnominals that will be displayed, but that RCVS Certs and Diplomas will remain.
The decision represents something of a victory for Victoria Lilley’s campaign and yet another indication that under the stewardship of Nick Stace, the RCVS really is evolving to become a more open, responsive organisation.
The competition is open to all UK-based undergraduate veterinary students and offers them the opportunity to work as a team to brainstorm, develop and present an innovative idea to a board of industry professionals.
Students can enter either as a single applicant or as a group (of roughly five members), with single applicants then being placed in a group with other applicants from their university. There can be more than one team representing each university.
Each student’s project can cover any aspect of veterinary health innovation. The RCVS suggests potential projects might include: innovations within veterinary education, innovations to improve sanitation and hygiene, innovations to improve veterinary-public communication and innovations to improve patient safety.
Entries must show how they have improved upon – or extended beyond – current expectations of best practice in their chosen area.
Each applicant will receive support from one of the Association of Veterinary Students’ (AVS) Vet Futures Ambassadors, as well as a mentor session with a chosen industry professional to guide them on their project.
Teams will need to submit three components for judging: a log of their progress throughout the project (which can include social media updates using the hashtag #ViVetStudentInnovation), mentor engagement and feedback, and a five-minute video ‘business pitch’.
The three finalist groups of the competition will be invited to present their pitch to a board of industry professionals at a ‘Dragon’s Den’ style event held at the RCVS ViVet 2019 Innovation Symposium on Tuesday 1 October 2019 in Manchester.
The winning and runner-up groups will then be selected and will be presented alongside the ‘mentor’s choice’ award. The Mentor’s Choice award will be selected by the team mentors. The prize will be awarded to an individual who shows excellence and enthusiasm within their work on the project.
Anthony Roberts, RCVS Director of Leadership & Innovation (pictured right), said: "This competition provides a great opportunity for veterinary students to engage with their fellow classmates across different fields of study and to work on projects that could genuinely make a difference to animal health and welfare and the way veterinary services are delivered. Teams will receive one-on-one mentoring and will be guided through the innovation process, developing skills that will be useful throughout their careers. We look forward to seeing the three finalist teams presenting at the RCVS ViVet Innovation Symposium in Manchester on 1 October."
Zoe Skinner, Vet Futures Student Representatives Team Leader, said: “This competition is a great opportunity for veterinary students to receive mentoring from experienced veterinary professionals and form contacts within our profession. It gives students a way to work together as a team and allows them to learn how to produce and develop innovative, problem-solving concepts as well as skills in delivering presentations. These are all important aspects of our career ahead, which will look brilliant on our CV’s.”
ViVet is now accepting registrations for the competition for the 2018/19 academic year. To enter, applicants must submit an online registration form. For further information, email info@vivet.org.uk.
The BVA Board oversees the performance of the Association and is responsible for corporate and financial governance and for setting the BVA’s strategic direction. It consists of nine members: the three Officers of the BVA, four Directors appointed by BVA Council and up to 2 non-veterinary Directors appointed by the Board. The Chairman is elected by the Board.
Philip, a Bristol University Veterinary School graduate, spent seven years in mixed practice in Sussex, Kent and Suffolk before embarking on a career in the veterinary pharmaceutical industry.
He became CEO of Novartis Animal Health UK Ltd in 1996 (where, incidentally, he was ultimately responsible for signing up a wet-behind-the-ears PR consultant by the name of Arlo Guthrie and giving the go-ahead for the development of vetnurse.co.uk, which in turn led to the launch of vetsurgeon.org). In 2003 he became the company's Head of Global Marketing, and in 2005, Head of Global Business Development.
Philip has also run business elective training at the Royal Veterinary College, which has provided first-hand experience of the concerns and opportunities facing new graduates within a changing profession.
Gudrun Ravetz, President of the British Veterinary Association, said: "We are delighted to announce Philip Lowndes as the new Chairman of the BVA Board. His experience and expertise in business, knowledge of the veterinary profession and involvement with BVA will be of great value as we continue to grow our membership and expand our services and support for vets, especially during the uncertainty caused by Brexit."
Philip holds previous chair experience, as Chairman of the National Office of Animal Health (NOAH) between 1997-2004, and currently sits as Chairman of both the Novartis UK Pension Trustee Board and its Investment Committee. He joined BVA’s Board in 2013 and was re-elected by BVA Council for a second term in 2016. He will be taking over from Derek Williams, who stepped down in March after seven years of tireless work as Chairman.
Gudrun said: "I also want to take this opportunity to thank Derek Williams for all the hard work he has put in over many years. In his role as Chairman Derek’s experience and expertise have been vital in helping BVA grow as an organisation."
Philip said: "I am honoured to be elected as the next Chairman of the BVA and look forward to chairing the Board as it addresses the challenges ahead. The veterinary profession needs and deserves vibrant representation and it is the Board’s role to ensure that the organisation has the ability and the resources to achieve this to the benefit of our membership."
The BVA Board also gained a new non-veterinary Board Director, Steven Anderson Dixon, from April. Mr Dixon brings with him a successful career in newspaper and magazine publishing, which will be an asset as BVA consolidates and continues to develop its portfolio of veterinary journals.
The authors say that the prognosis for dogs with stage II Kiupel high-grade cutaneous mast cell tumours has historically been considered poor.
However, the removal of metastatic regional lymph nodes in more recent research has been associated with a better outcome in canine cutaneous mast cell tumours.
For this study1, dogs with a histological diagnosis of overt lymph node metastasis that underwent lymphadenectomy (n = 31) were compared with those with a cytological diagnosis of regional lymph node metastasis, that did not undergo excision (n 18).
The study was a multi-institutional retrospective cohort study, using electronic medical records from four European institutions to identify dogs for inclusion.
The study found that dogs with Kiupel high-grade cutaneous mast cell tumours undergoing lymphadenectomy of HN3 lymph nodes as part of their primary surgery in addition to adjuvant medical treatment had a significant improvement in time to progression and survival time compared with those dogs not undergoing the procedure.
Lack of lymphadenectomy was the only variable significantly associated with a higher risk of nodal progression.
Dogs underwent lymphadenectomy of one peripheral lymph node in most cases.
The authors says that a higher number of lymph nodes or the removal of intracavitary lymph nodes might be associated with an increased incidence of postoperative morbidity.
They add that the findings warrant further exploration of the effect of surgical extirpation of metastatic sentinel lymph nodes and the number of lymph nodes removed on outcome in dogs with Kiupel high-grade cutaneous mast cell tumours.
Nicola Di Girolamo, Editor of JSAP said: “It is really encouraging to see collaborations from multiple institutions like the study presented here.
"Including multiple institutions in a retrospective cohort study, does not only ensure a higher sample size, but also ensure a higher generalisability of the results.
"Meaning that it is more likely that the differences observed in this study are also going to be observed at different practices and with different clinicians.”
https://onlinelibrary.wiley.com/doi/full/10.1111/jsap.13525
Reference
The new tool uses aggregated data from Banfield Pet Hospital medical records to identify whether a dog has a high, medium, or low risk of having PD based on the breed size1,2,3,4,5, age, and body condition the owner has stated3,4.
It also makes oral care recommendations based on the dog's history (e.g., diet, previous extractions, halitosis), clinical signs (e.g., bleeding gums) and current dental routine (e.g., tooth brushing).
Global Petcare R&D VP at Mars Pet Nutrition, Dr. Elise Malandain said: “This new risk assessment tool will help indicate to pet owners what level of risk their pet is at for developing this disease to help inform conversations with veterinary professionals about prevention or treatment.”
https://www.uk.pedigree.com/gum-disease-risk-checker
Woodley Equipment has launched the g-Pet species-specific glucose meter with a special introductory price of £9.50
Woodley says the g-Pet Glucometer makes testing quick easy and economical. Just insert a test strip, apply blood, and get results in 10 seconds.
The company highlights the following features of the new system:
Normal RRP is £49.50. Special introductory offer price is £9.50 for the next four weeks. Price includes meter, lancet, tips, 10 strips, manual, case and control solution.
For further information, or to organise a no-obligation in-practice demo, telephone 01204 669033 (option 1), or email: sales@woodleyequipment.com
Alternatively, visit www.woodleyequipment.com
The service, which has been set up by ex-Olympian Lisbet Stuer-Lauridsen (badminton for Denmark, since you ask), is designed to complement the end-of-life care already offered by practices.
Lisbet says that veterinary surgeons already working with Cloud 9 told her they found it difficult to offer the compassionate care pet owners need during a 15 minute consult in a busy practice.
The new service is structured so they have time to spend with the grieving owner to help support them at this sensitive time.
Pet owners make their booking with a dedicated Care Coordinator trained to handle the situation with dignity and respect.
Because the care is then provided at home, the pet doesn’t have to experience the potential anxiety involved in transport to the practice and the owner doesn’t have to worry about trying to hide their grief from other clients in the waiting room, or driving home in a distressed state.
Veterinary surgeons who apply to join the service are given specific training in euthanasia and counselling for all members of the family. The average visit time is expected to be around 1.5 hours to allow the procedure to be carried out with sensitivity and care.
Cloud 9 says the new service offers vets, locum vets and practices a flexible additional revenue stream. Vets can select the days or hours they want to work, to fit around family or other work commitments, and Cloud 9 says it will handle all the paperwork, including payments.
Cloud 9 Vets also offers additional services such as a memory wall and pet cremation.
Lisbet is now inviting vets throughout the country to sign up with Cloud 9’s mobile service. She said: "We want to offer the service in as many locations as possible and welcome the opportunity to work with locums, mobile vets and practices."
For more information, visit: https://cloud9vets.co.uk/join-the-team/
The Committee had found Dr Elefterescu guilty of serious professional misconduct in relation to a number of charges which covered issues such as dishonesty, poor record-keeping, and failure to carry out adequate clinical examinations.
The full charges and findings of the RCVS Disciplinary Committee can be found at: www.rcvs.org.uk/disciplinary.
The Judicial Committee of the Privy Council held the appeal hearing in October last year with three Justices of the Supreme Court - Lord Kerr, Lord Carnwath and Lord Kitchin – comprising the Board.
The basis of the appeal to the Privy Council was that the Committee’s findings on the facts of the case were flawed, with his counsel saying that Dr Elefterescu 'strenuously disputes the findings by the Committee of his dishonesty and lack of professional competence and submits that there is no adequate basis for them in the evidence’.
His counsel also told the Board that the Disciplinary Committee’s sanction failed to take into account mitigating factors and that the decision to remove Dr Elefterescu from the Register was disproportionate.
In relation to the appeal against the Disciplinary Committee’s findings on the facts, the Board was not persuaded by any of the arguments put forward on behalf of Dr Elefterescu. These arguments included that the RCVS had failed to call relevant witnesses and had failed to make Dr Elefterescu aware of the significance of some evidential matters, disclosed to him.
In respect of the sanction, the Board was also unpersuaded by the arguments put forward by Dr Elefterescu’s counsel, namely that it was too harsh in its assessment of aggravating factors, did not give adequate weight to mitigating factors, and that it failed to distinguish lack of competence from misconduct.
In its judgment on the arguments put forward by Dr Elefterescu’s counsel, the Board said: "It is the opinion of the Board that these criticisms are not well founded. The Committee considered with care Dr Elefterescu’s proven and admitted conduct in relation to each of the charges and whether it fell below or far below the standard to be expected. It is to be noted in this regard that a number of the charges which were either admitted or upheld were not the subject of any challenge on this appeal.
"Overall, the Committee found that Dr Elefterescu’s clinical failures were very serious, involved failures in the basics of animal care, resulted in animal suffering and involved widespread breaches of the respondent’s [RCVS] code of professional conduct. It also expressed particular concern about its findings of dishonesty, and rightly so. That conduct was, in its view, ‘at the top end’ of disgraceful conduct in a professional respect. What is more, Dr Elefterescu had a lack of insight into his failings and a wholly unjustified confidence in his abilities which constituted an ongoing risk to animal welfare."
"These were findings which the Committee was clearly entitled to make and, in the light of them, the Board is firmly of the view that the decision of the Committee to direct the removal of Dr Elefterescu’s name from the Register cannot be impeached. The Board rejects the criticisms made of the Committee’s reasoning and the conclusions to which it came. The direction that Dr Elefterescu’s name must be removed from the Register was appropriate and proportionate."
The Judicial Committee’s full findings can be found at www.jcpc.uk/cases/docs/jcpc-2018-0060-judgment.pdf.
The gilets, which normally cost $170, have three heating zones: one around the neck, one across the back of the shoulders and one which heats the pockets, all powered by a small battery.
VetSurgeon Editor Arlo Guthrie (pictured right) said: "As some members will know, I have a sideline reviewing gadgets and consumer tech on YouTube. Having reviewed the Ororo gilet, I bought a number of them for myself and my family, but thanks to a mix up by Amazon, I ended up with a spare men's XL size gilet (45-48 inch chest, 40-43 inch waist and 46-49 inch hip) .
"I'd like it to go to a good home, and I thought maybe a veterinary surgeon or nurse who now has to attend to clients in a frosty car park might be very glad of it.
"Of course, there are more women than men in the profession, so I'm going to offer one of the womens' vests too."
To win one of the gilets, watch the review here: https://www.youtube.com/watch?v=l84lRgEN1s4, then email: support@vetsurgeon.org with the answer to the following question:
On the medium heat setting, how long does the Ororo heated gilet stay warm?
First two correct answers out of the hat from those received by close of play next Wednesday (13th January) will get the gilets.
Arlo added: "Good luck, and a very happy New Year to you all. Let's hope we all get the vaccine soon.
"Oh, and if you enjoy the review, do subscribe on YouTube!"
The service uses an Xstrahl 100 superficial radiotherapy system, a £150,000 piece of equipment installed by Paragon after it was used successfully in the USA by the hospital's medical and radiation oncology specialist, Dr Rodney Ayl.
Rodney (pictured right) says the new equipment will transform the way Paragon can treat skin cancers, dermatological disorders and some other common superficial conditions.
He said: “This is a very exciting development for us and our clients because Xstrahl systems have been used so successfully in human medicine for many years.
“This prompted us to explore adapting the SRT system for veterinary use in the UK and we hope to collaborate with Colorado State University, which has a similar unit, to develop protocols for pets.
“We believe this will be a significant advance in the treatment and care of animals and we’re delighted to be at the forefront of introducing this new service.
“It is the only one of its kind for pets in the UK and there are very few units like this anywhere in the veterinary industry, so it really is an important move forward.”
Xstrahl radiotherapy systems were originally designed for the treatment of skin cancer, dermatological disorders, certain types of benign disease and some palliative care in humans.
Rodney says that having adapted the SRT system for animals will transform their treatment and the logistics and cost of getting radiation therapy for superficial skin conditions.
He added: “Superficial radiotherapy is particularly useful for treating some types of skin cancer where it may be preferable to surgery as it can deliver excellent non-invasive outcomes with curative or palliative intent.
“The treatment is less stressful from the outset and, thanks to its mechanism of action, it is also pain-free.
“Its use of different size cones, directly over the lesion, minimises effects on healthy skin and the fast treatment means a large reduction in time and impact on the patient’s day-to-day life, while providing a highly-effective treatment.
“The machine’s flexibility also makes it particularly suited for treating multiple lesions that are difficult to access, such as the head and neck, without changing patient positioning.
“The Xstrahl 100 system will help us to respond to the growing demand for radiation treatment and we can treat these patients on an outpatient basis, helping us to reduce surgical and hospitalisation costs.
“The technology is a real winner. It is easy to use and helps us to deliver safe and effective radiotherapy to our animal patients.
“It provides a quicker, easier, cheaper and non-invasive alternative for superficial tumours, especially in geriatric patients where surgery is not always an option. We’re looking forward to seeing the positive results here at Paragon.”
For more information, visit www.paragonreferrals.co.uk.
The study, titled “The utility of combined urine dipstick analysis and specific gravity measurement to determine feline proteinuria”, assessed the utility of the urine dipstick alone and combined with the urine-specific gravity (USG) for detecting proteinuria in cats.
For the study, the clinical records of cats presenting to a referral hospital between January 2011 and January 2017 were reviewed retrospectively.
To be eligible for inclusion, feline urine samples had to have undergone a complete urinalysis including dipstick evaluation, USG and urine protein-to-creatinine (UPC) measurement.
A total of 121 urine samples were included and diagnostic agreement and test accuracy were calculated for the dipstick test alone and in combination with the USG, using different cut-off values for proteinuria. Receiver-operating characteristic (ROC) curves were also calculated.
Jorge Pérez-Accino, corresponding author for the paper, said: “The diagnostic agreement between the urine dipstick and UPC ratio was poor and did not improve if the USG was considered together with the dipstick.
"A dipstick result of equal or greater than “Trace” (0.1-0.3g/L) had a sensitivity of 81% and a specificity of 31% to detect proteinuria.
"With regards the ROC curves, the area under the curve (AUC) of the urine dipstick alone was poor (0.57). When combined with the USG results, this improved to fair (0.78) but the specificity and negative predictive value (NPV) were still low.”
Nicola Di Girolamo, Editor of JSAP said: “These findings indicate that clinicians should not rely on the results of the urine dipstick test in combination with USG in cats for detecting proteinuria. Instead other quantitative methods, such as UPC ratio, should always be performed to detect proteinuria in cats.”
The full article can be found in the September issue of the Journal of Small Animal Practice which is free for BSAVA members. It can also be read online here: https://onlinelibrary.wiley.com/doi/10.1111/jsap.13184
The BSAVA has put together a collection of resources relating to urinalysis and proteinuria, available here: https://www.bsavalibrary.com/content/urinalysis--160
The expansion has increased the hospital's footprint by 30%, adding three new operating theatres, six new consult rooms and new feline facilities, including a cat-only waiting room, consult room and treatment area.
Hospital owner, IVC Evidensia said the expansion has been driven in part by the pet ownership boom of the last few years and increased demand for the hospital’s services.
To meet the demand, Vale has expanded its office space, adding desk space for a further 25 vets.
There are also new ultrasound and cardiology rooms, a new dental suite and enlarged prep and recovery areas.
The existing kennel area has doubled in size with the addition of nine new walk-in kennels, a bespoke isolation ward and secure outdoor runs.
Richard Artingstall, clinical director at Vale Referrals, said: “We’ve been working on this expansion for a long time and it’s incredible to see it complete.
"Our new and improved facilities mean we can give even more pets across the Southwest the gold standard treatment that they deserve and support our colleagues from neighbouring vet practices with extensive referral services.
"The feedback from pets and owners so far has been very rewarding to hear.”
The feedback from pets?
Really?
VetSurgeon.org contacted recent patient Dougal McDoggins for comment.
He said: "Woof."
www.valereferrals.co.uk.